Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis-Reference-Cited by-同舟云学术

Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

Published:2019-01 Issue:1 Volume:80 Page:158-167.e1
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Blauvelt Andrew,Simpson Eric L.,Tyring Stephen K.,Purcell Lisa A.,Shumel Brad,Petro Christopher D.,Akinlade Bolanle,Gadkari Abhijit,Eckert Laurent,Graham Neil M.H.,Pirozzi Gianluca,Evans Robert

Funder

Sanofi

Regeneron Pharmaceuticals

Publisher

Elsevier BV

Subject

Dermatology

Reference41 articles.

1. Prevalence of atopic dermatitis in Japanese adults;Muto;Br J Dermatol,2003

2. Global variations in prevalence of eczema symptoms in children from ISAAC phase three;Odhiambo;J Allergy Clin Immunol,2009

3. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study;Silverberg;J Allergy Clin Immunol,2013

4. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study;Silverberg;J Invest Dermatol,2015

5. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood;Barker;J Invest Dermatol,2007

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing Childhood and Adolescent Atopic Dermatitis in Primary Care: A US Expert Group Consensus;The Journal of Pediatrics: Clinical Practice;2024-12

2. Special Considerations in Atopic Dermatitis in Young Children;Dermatologic Clinics;2024-10

3. A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology;Annals of Allergy, Asthma & Immunology;2024-09

4. Current and Emerging Biologics for Atopic Dermatitis;Immunology and Allergy Clinics of North America;2024-09

5. Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity;Journal of Allergy and Clinical Immunology;2024-08